FRANCISCO JAVIER
LÓPEZ LONGO
Investigador hasta 2019
University of Michigan–Ann Arbor
Ann Arbor, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Michigan–Ann Arbor (2)
2020
-
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Respiratory Medicine, Vol. 8, Núm. 10, pp. 963-974
2017
-
Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy
Scientific Reports, Vol. 7